This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Canine B-Lymphocyte Antigen CD19 (CD19), C-His
Product Overview
BioVenic's Recombinant Canine B-Lymphocyte Antigen CD19 (CD19), C-His is a recombinant protein expressed from HEK293 Cells. Its predicted molecular weight is 32.3 kDa. The purity is>90% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
CD19, a B-cell coreceptor, is a transmembrane protein expressed throughout B-cell ontogeny, from the pro-B cell stage to the plasmablast stage. It is essential for B-cell development and function, making it a promising target for antibody-directed immunotherapies against B-cell malignancies. In dogs, CD19 is encoded by the CD19 gene.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.